• UTMB to terminate Aetna contract

    The University of Texas Medical Branch is terminating its commercial contract with Aetna because the insurance company does not pay UTMB at a competitive rate. UTMB has sent a letter of termination to Aetna that calls for termination of the contract effective May 6, 2021.

  • UTMB study shows spike mutation in COVID-19

    A multidisciplinary team from The University of Texas Medical Branch at Galveston has shown a dominant mutation D614G of the SARS-CoV-2 spike protein enhances viral replication in the upper respiratory airway, which may contribute to the increased transmission of COVID-19. This finding is important in understanding the evolution of SARS-CoV-2 as well as in the development of vaccines and therapeutic antibodies. The study is currently available in Nature.

  • Dr. Suresh Bhavnani banner

    Data science driven by a family need

    Dr. Suresh Bhavnani, a biomedical informatics researcher, was used to dealing with detailed medical data and spreadsheets full of numbers and complex statistics. However, when his mother fractured her hip, the anonymous numbers suddenly became personal.

  • Foy to join UTMB as VP, Audit Services

    The University of Texas Medical Branch announced today that Desolyn Foy will join the university on Nov. 2, 2020, as vice president, Audit Services. Most recently, Foy was vice president, Advanced Analytics and Continuous Control Monitoring for Harris Health System.

  • Biological markers graphic

    Biological markers may let doctors know who gets sicker from COVID-19

    For some, COVID-19 can come and go leaving no trace and no symptoms. For others, the disease responsible for the worldwide pandemic can lead to a range of painful symptoms, a trip to an intensive care unit, and even death. How to tell who will be spared and who will be hard hit?

  • UTMB researchers identify proteins that block immune response to COVID-19

    Researchers from The University of Texas Medical Branch at Galveston have discovered SARS-CoV-2 proteins that suppress the body's immune response, thereby enabling infection and transmission of the disease. The findings, recently published in the major research journal, Cell Reports, are paramount to understanding the biology of Covid-19 and to developing new vaccines against the disease.

  • UTMB awarded $1.4 million to help reduce teen pregnancies

    The University of Texas Medical Branch has been awarded a two-year, $1.4 million grant focused on helping reduce teen pregnancies. Nearly a quarter of a million babies are born to adolescent females each year. The principal investigator of the study, Dr. Jeff Temple, says the “impacts of teen pregnancy are substantial and persist across the lifespan.”

  • 50 Experts to Trust in a Pandemic

    UTMB’s Vineet Menachery was named one of the 50 people to follow during a pandemic by Elemental, a health and science publication by Medium. Menachery leads one of the few labs in the country that was studying coronaviruses before the pandemic began.

  • The NIH Launches a Global Hunt for Animal-to-Human Diseases

    “We’ve all learned the hard way that every time there is an emergence, that triggers some sort of disorganized scramble,” UTMB's Nikos Vasilakis tells WIRED. UTMB is part of a new network to detect and respond when pathogens jump from wildlife to humans.

  • The Sealy & Smith Foundation establishes John Sealy Distinguished Chair in Innovations in Molecular Biology at UTMB

    A $1 million gift from The Sealy & Smith Foundation has established the John Sealy Distinguished Chair in Innovations in Molecular Biology at The University of Texas Medical Branch. Dr. Pei-Yong Shi, a professor in the Biochemistry and Molecular Biology Department and vice chair for Innovation and Commercialization, has been named the inaugural recipient.